Physician profile
George E Platt
NPI 1700881158
$53,181.15
in general payments reported to CMS, 2019-2025
63 companies · $5,367 in 2025
The $5,367 reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $8,879 · 2020: $22K · 2021: $5,373 · 2022: $4,008 · 2023: $5,112 · 2024: $2,716 · 2025: $5,367.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Consulting Fee: $2,130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,063.99 |
| Consulting Fee | $2,130.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $30,427.67 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $3,547.69 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Amgen INC. | $2,964.64 | 2019-2025 | Evenity, Otezla, Repatha |
| Glaxosmithkline, LLC. | $2,607.61 | 2019-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Inari Medical, INC. | $1,427.95 | 2021-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Lilly USA, LLC | $1,223.15 | 2019-2025 | Mounjaro, Kisunla, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $1,025.78 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $814.16 | 2020-2025 | Jardiance, Ofev |
| Abbott Laboratories | $770.15 | 2019-2025 | Freestyle Libre 3, Mitraclip, Freestyle Libre 2 |
| Janssen Pharmaceuticals, INC | $678.38 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $632.06 | 2019-2025 | |
| Daiichi Sankyo INC. | $516.17 | 2019-2025 | Injectafer |
| Abiomed | $481.99 | 2021-2025 | Impella |
| Medtronic, INC. | $461.61 | 2022-2025 | Venaseal, Intellis Adaptivestim |
| Merck Sharp & Dohme LLC | $437.01 | 2019-2025 | Verquvo, Capvaxive, Gardasil 9 |
Show all 63 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $388.25 | 2020-2024 | Korlym |
| Pfizer INC. | $332.86 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $325.94 | 2019-2022 | |
| Boston Scientific Corporation | $321.30 | 2019-2025 | General - Pain Management |
| Astellas Pharma US INC | $301.08 | 2019-2023 | Veozah, Myrbetriq |
| Abbvie INC. | $295.50 | 2019-2023 | |
| Exact Sciences Corporation | $234.47 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Amarin Pharma, INC. | $230.23 | 2019-2022 | |
| Mannkind Corporation | $172.44 | 2021 | |
| Esperion Therapeutics, INC. | $171.81 | 2020-2024 | Nexletol |
| Silk Road Medical, INC. | $164.96 | 2021 | |
| Recor Medical INC | $161.38 | 2025 | Paradise Ultrasound Renal Denervation System |
| Idorsia Pharmaceuticals US INC | $147.50 | 2022-2025 | Quviviq, Quviviq |
| Endo Pharmaceuticals INC. | $142.69 | 2019-2022 | |
| Avanir Pharmaceuticals, INC. | $127.33 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $125.00 | 2022 | |
| Scpharmaceuticals INC. | $124.99 | 2025 | |
| Painteq LLC | $120.74 | 2024 | Painteq |
| Sunovion Pharmaceuticals INC. | $118.59 | 2019-2022 | |
| Grifols USA, LLC | $114.69 | 2020 | |
| Exactech, INC. | $108.69 | 2019 | |
| Edwards Lifesciences Corporation | $102.19 | 2025 | Sapien 3 Ultra Resilia |
| Ascensia Diabetes Care US INC. | $87.36 | 2024-2025 | |
| Nestle Healthcare Nutrition INC. | $70.40 | 2021-2023 | |
| Ars Pharmaceuticals Operations, INC. | $69.10 | 2025 | Neffy |
| Horizon Therapeutics Plc | $62.77 | 2022-2023 | Krystexxa |
| Hikma Pharmaceuticals USA | $60.87 | 2019-2021 | |
| Portola Pharmaceuticals, LLC | $46.71 | 2019 | |
| Dexcom, INC. | $45.04 | 2021-2023 | Dexcom G6 Transmitter |
| Biohaven Pharmaceuticals, INC. | $43.82 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $35.39 | 2023-2025 | Rexulti |
| Arbor Pharmaceuticals, INC. | $28.61 | 2020 | |
| Phathom Pharmaceuticals, INC. | $28.44 | 2025 | Voquezna |
| Clarus Therapeutics INC. | $28.17 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $25.95 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $23.55 | 2024 | Gemtesa |
| Irhythm Technologies, INC. | $18.99 | 2022 | |
| Eyevance Pharmaceuticals LLC | $17.92 | 2021 | |
| Insulet Corporation | $17.09 | 2025 | Omnipod |
| Pulmonx Corporation | $16.45 | 2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| Noven Therapeutics, LLC | $15.91 | 2024 | Xelstrym |
| Aimmune Therapeutics, INC. | $15.35 | 2024 | |
| Axonics, INC. | $14.90 | 2020 | |
| Philips North America LLC | $13.95 | 2024 | (Ck7) Extended Holter |
| Cequr Corporation | $12.38 | 2024 | Cequr Simplicity |
| Allergan, INC. | $11.43 | 2019 | |
| Gilead Sciences, INC. | $11.16 | 2020 | |
| Eisai INC. | $10.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$153,381.77 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Platt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.